1 IRB IRB Inspections Inspections Melody Lin, Ph.D. Melody Lin, Ph.D. Deputy Director, Office for Human Research Deputy Director, Office for Human Research Protections Protections Director, International Activities Director, International Activities [email protected][email protected]Santiago, Chile Santiago, Chile August 2006 August 2006
IRB Inspections. Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities [email protected] Santiago, Chile August 2006. Objectives. Inspections Program OHRP FDA Tips for Preparation Common Deficiency Behavioral Guidelines. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
IRB IRB InspectionsInspections
Melody Lin, Ph.D.Melody Lin, Ph.D.Deputy Director, Office for Human Research ProtectionsDeputy Director, Office for Human Research ProtectionsDirector, International ActivitiesDirector, International [email protected]@hhs.gov
Santiago, ChileSantiago, Chile
August 2006August 2006
2
ObjectivesObjectives
Inspections ProgramInspections Program– OHRPOHRP
– FDAFDATips for PreparationTips for PreparationCommon DeficiencyCommon DeficiencyBehavioral GuidelinesBehavioral Guidelines
Receive allegation of noncomplianceReceive allegation of noncompliance Determine OHRP jurisdiction Determine OHRP jurisdiction Written inquiry to appropriate Written inquiry to appropriate
institutional officialsinstitutional officials Review of institution’s report and Review of institution’s report and
Purpose of OHRP Not-for Purpose of OHRP Not-for Cause EvaluationsCause Evaluations
To assess institutional compliance To assess institutional compliance with 45 CFR 46with 45 CFR 46
In absence of specific allegationsIn absence of specific allegations Somewhat proactiveSomewhat proactive Some evaluations are partially “for Some evaluations are partially “for
(ineligible for HHS research support)(ineligible for HHS research support)
Compliance Oversight Compliance Oversight Investigation Possible Investigation Possible Determinations/Outcomes Determinations/Outcomes (3)(3)
15
FDA IRB InspectionsFDA IRB Inspections
Selection CriteriaSelection Criteria– Past inspection historyPast inspection history
Frequency Frequency Compliance statusCompliance status
– Activity of IRBActivity of IRB
– New IRBsNew IRBs
– ComplaintsComplaints
16
FDA IRB InspectionsFDA IRB Inspections
RoutineRoutine– Inspections assigned on cyclic Inspections assigned on cyclic
basis for surveillancebasis for surveillanceDirectedDirected
– Complaints to FDAComplaints to FDA FDA, other agenciesFDA, other agencies Sponsor/monitorSponsor/monitor Subjects/PublicSubjects/Public
17
FDA IRB InspectionsFDA IRB Inspections
Inspections are announced and Inspections are announced and scheduled in advancescheduled in advance– Consist of interviews with responsible Consist of interviews with responsible
IRB staffIRB staff
– In-depth review of SOPs , files and In-depth review of SOPs , files and records records
– Active Active FDA regulated studiesFDA regulated studies
18
Scope of FDA IRB Scope of FDA IRB InspectionsInspections
IRB membershipIRB membershipWritten procedures Written procedures Initial review and approval of Initial review and approval of
studiesstudiesContinuing review of researchContinuing review of research
19
Scope of FDA IRB Scope of FDA IRB InspectionsInspections
IRB reporting to investigator and IRB reporting to investigator and institutioninstitution
Discuss IRB administration and Discuss IRB administration and proceduresprocedures– Individual responsibility and authorityIndividual responsibility and authority
– MembershipMembership
– OperationsOperations
– Record keeping requirementsRecord keeping requirements
– Review and approval of informed Review and approval of informed consentconsent
FDA IRB InspectionsFDA IRB Inspections
21
FDA IRB InspectionsFDA IRB Inspections
Record ReviewRecord Review– SOPsSOPs
Must have written procedures as Must have written procedures as required by 21 CFR 58.108required by 21 CFR 58.108
Should agree with procedures Should agree with procedures described during interviewdescribed during interview
22
FDA IRB InspectionsFDA IRB Inspections
Inspection of IRB files-FDA regulated Inspection of IRB files-FDA regulated study filesstudy files– Minutes of meetingsMinutes of meetings– List of IRB members List of IRB members – Documents submitted to IRB to obtain Documents submitted to IRB to obtain
study approvalstudy approval– Correspondence between IRB and Correspondence between IRB and
investigatorinvestigator– Records of continuing reviewRecords of continuing review– Any other recordsAny other records
23
Conclusion of FDA IRB Conclusion of FDA IRB InspectionInspection
Exit interview with managementExit interview with management– Discussion of inspection findingsDiscussion of inspection findings
– Issuance of an FDA 483Issuance of an FDA 483
24
Post FDA IRB InspectionPost FDA IRB Inspection
Detailed Narrative Report PreparedDetailed Narrative Report PreparedSubmitted to HQ BIMO Staff for Submitted to HQ BIMO Staff for
EvaluationEvaluation
25
FDA Compliance Inspection FDA Compliance Inspection ClassificationClassification(1)(1)
NAI – No Action IndicatedNAI – No Action Indicated VAI – Voluntary Action IndicateVAI – Voluntary Action Indicate
– Objectionable conditions or practices were Objectionable conditions or practices were found, but FDA is not prepared to take or found, but FDA is not prepared to take or recommend any administrative of recommend any administrative of regulatory actionregulatory action
26
FDA Compliance Inspection FDA Compliance Inspection ClassificationClassification(2)(2)
OAI – Official Action IndicatedOAI – Official Action Indicated– Regulatory and/or Administrative Regulatory and/or Administrative
actions will be recommended due to actions will be recommended due to significant objectionable observationssignificant objectionable observations
27
Tips Tips Prior to InspectionPrior to Inspection(1)(1)
Know what the regulatory Know what the regulatory requirements are for your requirements are for your operationsoperations– 21 CFR 50 and 56 IRBs and informed 21 CFR 50 and 56 IRBs and informed
consentconsent
– 21 CFR 312 Clinical Investigators and 21 CFR 312 Clinical Investigators and Sponsors of Drugs and biologicsSponsors of Drugs and biologics
– 21 CFR 812 Clinical Investigators of 21 CFR 812 Clinical Investigators of Medical DevicesMedical Devices
28
Tips Prior to InspectionTips Prior to Inspection(2)(2)
Obtain and be familiar with the Obtain and be familiar with the Compliance Program covering your Compliance Program covering your operationoperation
Retain all records necessary to Retain all records necessary to completely reconstruct activities completely reconstruct activities and findingsand findings
29
Tips During the Tips During the Inspection Inspection (1) (1)
Have the most responsible Have the most responsible personnel available personnel available – IRB ChairIRB Chair
– IRB administrator/Exec. Sec.IRB administrator/Exec. Sec.
– Institutional officialInstitutional official
30
Tips During the Tips During the InspectionInspection(2)(2)
Have all records readily available Have all records readily available and organizedand organized
Be available throughout the Be available throughout the inspection to answer questionsinspection to answer questions
31
Tips During Inspection Tips During Inspection (3)(3)
Update records, organized and be Update records, organized and be availableavailable– Inventory of ongoing research and current Inventory of ongoing research and current
statusstatus– IRB SOPs covering current practicesIRB SOPs covering current practices– IRB membership rosters, current and pastIRB membership rosters, current and past– IRB meeting minutesIRB meeting minutes– Records of tracked studiesRecords of tracked studies
CorrespondenceCorrespondence– Sent to IRB Chair Sent to IRB Chair
– Describes which practices or Describes which practices or conditions, were determined to be conditions, were determined to be objectionableobjectionable
– Letters are sent for serious Letters are sent for serious noncompliance and require a response noncompliance and require a response
• IRB failure to review grant applicationsIRB failure to review grant applications• IRB lacks sufficient information to IRB lacks sufficient information to
make determinations make determinations • Inadequate continuing review, or Inadequate continuing review, or
longer than 1 yearlonger than 1 year• Inadequate IRB review at convened Inadequate IRB review at convened
meetingsmeetings
• IRB failure to review grant applicationsIRB failure to review grant applications• IRB lacks sufficient information to IRB lacks sufficient information to
make determinations make determinations • Inadequate continuing review, or Inadequate continuing review, or
longer than 1 yearlonger than 1 year• Inadequate IRB review at convened Inadequate IRB review at convened
meetingsmeetings
34
• Contingent approval without Contingent approval without subsequent re-reviewsubsequent re-review
• IRB meetings without a quorumIRB meetings without a quorum• IRB members with conflicts of interestIRB members with conflicts of interest• Inadequate records, minutes, files, Inadequate records, minutes, files,
documentation, policies and documentation, policies and proceduresprocedures
• Contingent approval without Contingent approval without subsequent re-reviewsubsequent re-review
• IRB meetings without a quorumIRB meetings without a quorum• IRB members with conflicts of interestIRB members with conflicts of interest• Inadequate records, minutes, files, Inadequate records, minutes, files,
documentation, policies and documentation, policies and proceduresprocedures
– Vote not recorded by number of votesVote not recorded by number of votes
– Adverse events not adequately reviewedAdverse events not adequately reviewed
38
Majority of members not at Majority of members not at meeting meeting
Majority of members not present Majority of members not present for votefor vote
Non-scientific member not presentNon-scientific member not presentFail to report to FDA when study is Fail to report to FDA when study is
suspended or terminatedsuspended or terminated
Common IRB Deficiencies Common IRB Deficiencies (FDA)(FDA)
39
Behavioral Behavioral GuidelinesGuidelines
40
Rules to Follow During Rules to Follow During InspectionInspection
Know the contents of your job Know the contents of your job descriptiondescription
Be aware of your body languageBe aware of your body languageNever remain in the room to chat Never remain in the room to chat
with a inspector after you have with a inspector after you have answered all inspection related answered all inspection related questions.questions.
41
More to do’s…More to do’s…
Be yourselfBe yourselfRemain focusedRemain focusedAnswer only the question askedAnswer only the question asked
42
More to do’s…More to do’s…
Think before you answer. There Think before you answer. There are no bonus points for being fastare no bonus points for being fast
Remain calm, remember you do Remain calm, remember you do your job every day, and no one your job every day, and no one knows your job as well as youknows your job as well as you
43
What is Redacting?What is Redacting?
Redacting is the act of selecting Redacting is the act of selecting or adapting for publication or or adapting for publication or releaserelease
Remove all information that the Remove all information that the inspector is not legally entitled to inspector is not legally entitled to seesee
44
Use Caution During Use Caution During InspectionInspection
Don’t fill in the silencesDon’t fill in the silencesDon’t allow yourself to become Don’t allow yourself to become
irritated. Maintain a professional irritated. Maintain a professional demeanor at all timesdemeanor at all times
45
Answer all “yes” or “no” Answer all “yes” or “no” questions with “yes" or “no”questions with “yes" or “no”
Do not editorialize or volunteer Do not editorialize or volunteer informationinformation
More cautions…More cautions…
46
More cautions…More cautions…
Never hand a document directly Never hand a document directly to a inspector - - - always pass to a inspector - - - always pass documents to the inspection documents to the inspection team leadersteam leaders
47
More cautions…More cautions…
Never volunteer information on Never volunteer information on any subjectany subject
Never refer to another topic, Never refer to another topic, area, or procedure when area, or procedure when answering a questionanswering a question
48
Body LanguageBody Language
Do not sit on the edge of your Do not sit on the edge of your chair, chair,
Make eye contactMake eye contactDo not play with your hair, twirl Do not play with your hair, twirl
your thumbs, click your ink pin, your thumbs, click your ink pin, or tap your fingersor tap your fingers
49
Body LanguageBody Language
Do not watch the doorDo not watch the doorNever cross your arms over your Never cross your arms over your
chest or slouch in your chairchest or slouch in your chair
50
Statement to Avoid…Statement to Avoid…
““It’s supposed to do (fill in the It’s supposed to do (fill in the blank).”blank).”
““Wow, it usually never does it right Wow, it usually never does it right the first time!”the first time!”
““Do you want to know how it is Do you want to know how it is supposed to happen or how it supposed to happen or how it really happens?”really happens?”
51
Statement to Avoid…Statement to Avoid…
““I didn’t even know we had an SOP I didn’t even know we had an SOP for that!”for that!”
““I didn’t even know the SOP said I didn’t even know the SOP said that.”that.”
““I don’t know (with no follow-up).”I don’t know (with no follow-up).”
52
Statement to Avoid…Statement to Avoid…
““Let me show you what we do for Let me show you what we do for Pfizer (or any other client).”Pfizer (or any other client).”
““Would you like to see all our Would you like to see all our metrics?”metrics?”
““Well, I can try to do that for you, Well, I can try to do that for you, but I’ve never really been trained.”but I’ve never really been trained.”